Resources

What Is CAR-T Cell Therapy? An Educational Overview From The Team At Cell Therapies

CAR-T cell therapy is a form of immunotherapy that uses a patient's own T-cells…

Ryan HardingAugust 12, 2026

Resources

Translating innovative cell therapies: What is GMP?

The cell therapy sector is growing rapidly and within it, cell-based therapies derived from human…

Cell TherapiesJune 12, 2026

Resources

The Australian Advantage

Why do CDMO’s in Europe, Asia and the US look to Australia for early stage…

Ryan HardingFebruary 27, 2026

Resources

Technology Transfers for CGT products: Understanding what is needed for success

Transferring a cell and gene therapy (CGT) product from development to manufacturing involves a detailed…

Cell TherapiesJune 20, 2024

Resources

Quality Assurance: The Importance of Robust Investigations

Quality Assurance: The Importance of Robust Investigations Quality Assurance (QA) is a broad process that…

Cell TherapiesApril 22, 2024

Resources

Ensuring Every Batch is a Success: Validation and Qualification

Ensuring Every Batch is a Success: Validation and Qualification in Cell and Gene Therapy Manufacturing…

Cell TherapiesMarch 10, 2024

Resources

Translating research discoveries to commercialised cell and gene therapy products; asking the right questions as an academic.

When translating research discoveries in the cell and gene therapy sector, numerous considerations must be…

Cell TherapiesNovember 28, 2023

Resources

From Concept to Commercialisation: Why the selection of an organisation for a cell and gene therapies can impact your patient outcomes and competitive advantage

The development pipeline of cell and gene therapies faces numerous obstacles while striving for the…

Cell TherapiesAugust 14, 2023

Resources

Why Australia should be your choice for CGT development

The development of cell and gene therapy is rapidly growing in our industry with a…

Cell TherapiesFebruary 22, 2023

Filter

What Is CAR-T Cell Therapy? An Educational Overview From The Team At Cell Therapies

Cell Therapies Supports Commencement of Australian Phase I/Ib Clinical Trial of A-SEEDS’ ACS2015 CAR-T Therapy for Solid Tumours

Translating innovative cell therapies: What is GMP?

Resources

What Is CAR-T Cell Therapy? An Educational Overview From The Team At Cell Therapies

Translating innovative cell therapies: What is GMP?

The Australian Advantage

Technology Transfers for CGT products: Understanding what is needed for success

Quality Assurance: The Importance of Robust Investigations

Ensuring Every Batch is a Success: Validation and Qualification

Translating research discoveries to commercialised cell and gene therapy products; asking the right questions as an academic.

From Concept to Commercialisation: Why the selection of an organisation for a cell and gene therapies can impact your patient outcomes and competitive advantage

Why Australia should be your choice for CGT development

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate